Filter Results:
(54)
Show Results For
- All HBS Web
(637)
- People (2)
- News (54)
- Research (449)
- Events (2)
- Multimedia (8)
- Faculty Publications (395)
Show Results For
- All HBS Web
(637)
- People (2)
- News (54)
- Research (449)
- Events (2)
- Multimedia (8)
- Faculty Publications (395)
Page 1 of 54
Results →
Sort by
- 07 Apr 2016
- News
Sanofi Genzyme Donates Corporate Archives to Harvard Business School
- 03 Aug 2010
- News
Analysis: Rare diseases lure Sanofi, other big drugmakers
- 04 Jun 2010
- News
Another View: Can Biotech Survive Icahn?
- 03 Dec 2012
- News
In World of Big Stuff, the U.S. Still Rules
- 15 Feb 2011
- News
Who will blink in Genzyme, Sanofi price talks?
- 08 Jan 2018
- News
What Do Investors and Companies Talk About?
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
focused on patients. “Patients and their families are at the center of why I want to be in the biotechnology space,” she concludes. “When you’re working on rare diseases, it’s hard not to feel like you’re making a difference.” View Details
- 31 Jan 2014
- News
Body, Heal Thyself
Chien and Derrick Rossi, published a paper in the journal Nature Biotechnology that showed mRNA Therapeutics was capable of stimulating blood vessel growth, repairing damaged heart tissue, and helping a mouse through myocardial... View Details
- 01 Aug 1998
- News
High Honors
education." McDermott hasn't slowed down in retirement, concentrating his energy and vision on an array of community-related projects. Among them is the Texas Research and Technology Foundation, which he established in 1984 to develop San Antonio's Texas Research Park,... View Details
- 01 Feb 2002
- News
Health Industry Alumni Convene for Conference
and CEO of Mediconsulting, Inc., spoke about creating a better model for business collaborations between biotech and pharmaceutical firms. Said Klietmann, the conference's biotechnology chair and a lecturer in pathology at Harvard Medical... View Details
- 01 Jun 2000
- News
The Business of Biotech
heralding the start of National Biotechnology Month, as January 2000 had been designated by the U.S. Senate. For biotech, in fact, the party had begun months earlier, when hundreds of millions of dollars had poured into promising... View Details
Keywords: Julia Hanna
- 01 Apr 2000
- News
Porter's Paradox
decisive, enduring advantages, therefore, become unique local centers of innovation for the likes of mutual funds, venture capital, and biotechnology in Greater Boston or aircraft equipment and design, boat- and shipbuilding, and metal... View Details
- 06 Dec 2021
- News
Research Brief: Launching into a Downturn
labor market—but stays the same for those in more stable job categories. Examining the performance of 3,025 founders and their 1,747 startups in the biotechnology and medical-device sectors during previous economic downturns, Roche and... View Details
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift... View Details
Keywords: Anne Kavanagh
- 01 Jun 2000
- News
Managing the Map
We are at the dawn of a new epoch in the world of science, one that will cast strong light on a unique corner of the biotechnology field known as genomics. The designation refers to the study of genes, those chemical building blocks of... View Details
Keywords: Peter K. Jacobs
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
entrepreneur who has had a successful career in business, finance, yachting, and philanthropy. He is the former CEO of Serono SA (formerly known Ares-Serono), a family-controlled global pharmaceuticals and biotechnology leader whose roots... View Details
- 01 Dec 2003
- News
The Next Big Thing
research and commercialization of biotechnology and biomedicine, the life sciences’ core activities? And what steps must be taken to maintain preeminence? In a keynote presentation at a September “Massachusetts Life Sciences Summit,” HBS... View Details
- 01 Dec 1996
- News
New Releases
a competitive factor. In a three-year study of pharmaceutical and biotechnology firms, Pisano shows that the development of distinctive and superior process technologies can lower costs, improve quality, and increase flexibility. He... View Details